Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Benjamin Scirica MD
Benjamin Morgan Scirica MD Associate Editor
Peter Libby MD
Peter Libby MD Advisory Board
Anne Valente MD
Anne Marie Valente MD Advisory Board
See All Experts
featured
Published in Cardiology

Expert Opinion / Commentary · May 01, 2014

Between a Rock and a Hard Place: The Perils of Anticoagulation

Benjamin Scirica MD

 

 Save  Recommend
 Share

Additional Info

  1. Ruff CT, Giugliano RP, Braunwald E, et al, Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-962.
  2. EM Hylek EM, Held C, JH Alexander JH, et al. Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin in the ARISTOTLE Trial: Predictors, Characteristics, and Clinical Outcomes [published online ahead of print March 5, 2014]. J Am Coll Cardiol. doi: 10.1016/j.jacc.2014.02.549.

Disclosure statements are available on the authors' profiles:

Benjamin Scirica MD

Further Reading

Most Read This Week

Recently Updated